Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elad Sharon, M.D.

Concepts (312)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Elad Sharon's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Elad Sharon has written about over time.
GPI-Linked Proteins, 5 publications between 2010 and 2014, average publication date September 2012. Drug Discovery, 3 publications between 2011 and 2017, average publication date May 2014. Biliary Tract Neoplasms, 3 publications between 2012 and 2022, average publication date December 2018. Clinical Trials as Topic, 13 publications between 2011 and 2024, average publication date February 2019. Immunotherapy, 24 publications between 2011 and 2024, average publication date October 2019. Neoplasms, 39 publications between 2010 and 2024, average publication date November 2019. Antineoplastic Combined Chemotherapy Protocols, 27 publications between 2010 and 2024, average publication date February 2021. Carcinoma, Non-Small-Cell Lung, 8 publications between 2014 and 2024, average publication date July 2021. Medical Oncology, 9 publications between 2017 and 2024, average publication date July 2021. Melanoma, 13 publications between 2014 and 2024, average publication date October 2021. Antibodies, Bispecific, 4 publications between 2021 and 2024, average publication date October 2022.

To see the data from this visualization as text, click here.
Sharon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (312)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.